Dibekacin

DB13270ApprovedSmall molecule

Dibekacin is an aminoglycoside antibiotic marketed in Japan .

Chemical structure of Dibekacin
Formula / weight
C18H37N5O8 · 451.521 g/mol (avg)

Resolves to

Compound
UNII45ZFO9E525CAS34493-98-6ChEMBLCHEMBL560976ChEBI37945KEGGD07811
Clinical / RWD
RxNorm3328ATCJ01GB09ATCS01AA29
Structure
InChIKeyJJCQSGDBDPYCEO-XVZSLQNASA-NSMILESNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1

What you can answer from here — as of September 13, 2026

875Drug interactionsStructured to mechanism, not free text
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
2ATC codesIncluding every combination product, plus 14 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Dibekacin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In